View Item 

Show simple item record

Connective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseases
dc.contributor.authorMacCarter, Daryl K.en_US
dc.contributor.authorHossler, Paul A.en_US
dc.contributor.authorCastor, C. Williamen_US
dc.date.accessioned2006-04-07T18:02:07Z
dc.date.available2006-04-07T18:02:07Z
dc.date.issued1981-09-10en_US
dc.identifier.citationMacCarter, Daryl K., Hossler, Paul A., Castor, C. William (1981/09/10)."Connective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseases." Clinica Chimica Acta 115(2): 125-134. <http://hdl.handle.net/2027.42/24260>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T57-47RK24Y-39J/2/773fa1e64346c32be0602f334d22cbc4en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/24260
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6974622&dopt=citationen_US
dc.description.abstractPlasma levels of the CTAP-III antigen were measured by radioimmunoassay in 80 patients with rheumatic diseases. Patients with clear evidence of vasculitis usually exhibited increased plasma CTAP-III antigen. In both systemic lupus erythematosus and rheumatoid arthritis, there appeared to be a correlation between pCTAP-III values and other laboratory and clinical parameters of disease activity.en_US
dc.format.extent662356 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleConnective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseasesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPathologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumRackham Arthritis Research Unit, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationumRackham Arthritis Research Unit, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationumRackham Arthritis Research Unit, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI 48109, U.S.A.en_US
dc.identifier.pmid6974622en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/24260/1/0000523.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0009-8981(81)90068-1en_US
dc.identifier.sourceClinica Chimica Actaen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0000523.pdf
Size:
646.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.